Variant report
Variant | nsv967952 |
---|---|
Chromosome Location | chr4:120938383-120953526 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:5)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:5 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MAD2L1-3 | chr4:120943327-120943495 | ucscGeneNc_uc003idk_1 |
2 | lnc-MAD2L1-3 | chr4:120939709-120939839 | ucscGeneNc_uc003idk_1 |
3 | lnc-MAD2L1-3 | chr4:120945055-120945118 | ucscGeneNc_uc003idk_1 |
4 | lnc-MAD2L1-3 | chr4:120941955-120941997 | ucscGeneNc_uc003idk_1 |
5 | lnc-MAD2L1-3 | chr4:120941240-120941365 | ucscGeneNc_uc003idk_1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs147376428 | chr4:120939798-120939799 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs183161103 | chr4:120940004-120940005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143944962 | chr4:120940008-120940009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs17374008 | chr4:120940014-120940015 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs150695984 | chr4:120940049-120940050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs139954752 | chr4:120940113-120940114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs17374036 | chr4:120940133-120940134 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs149776951 | chr4:120940175-120940176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs144692332 | chr4:120940181-120940182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371246494 | chr4:120940248-120940249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548884334 | chr4:120940250-120940251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541990696 | chr4:120940271-120940272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs139497958 | chr4:120940299-120940300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531406356 | chr4:120940324-120940325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs150063110 | chr4:120940328-120940329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs144336979 | chr4:120940405-120940406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375837425 | chr4:120940407-120940408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533537396 | chr4:120940420-120940421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559426918 | chr4:120940434-120940435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs146575602 | chr4:120940515-120940516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567290061 | chr4:120940528-120940529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536912213 | chr4:120940533-120940534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186076191 | chr4:120940548-120940549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576661986 | chr4:120940575-120940576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs140342273 | chr4:120940576-120940577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs3956507 | chr4:120941284-120941285 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs574490903 | chr4:120941300-120941301 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs543454465 | chr4:120941345-120941346 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs199595755 | chr4:120941996-120941997 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs185259718 | chr4:120943415-120943416 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs116258738 | chr4:120943425-120943426 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs137972685 | chr4:120943461-120943462 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs369035254 | chr4:120943468-120943469 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs144324588 | chr4:120943800-120943801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs116731625 | chr4:120943828-120943829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs568259408 | chr4:120943893-120943894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537286715 | chr4:120944019-120944020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148344509 | chr4:120944039-120944040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs141593148 | chr4:120944081-120944082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150901697 | chr4:120944108-120944109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs34171123 | chr4:120944125-120944126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs188842700 | chr4:120944130-120944131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs139562662 | chr4:120944141-120944142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181080856 | chr4:120944157-120944158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs562090292 | chr4:120944246-120944247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs186120370 | chr4:120944258-120944259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544512742 | chr4:120944267-120944268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs144176845 | chr4:120944316-120944317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs76010331 | chr4:120944324-120944325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs12649550 | chr4:120944333-120944334 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Clear cell renal cell carcinoma | 18791270 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Gastric cancer | 16891809 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:120940000-120940400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr4:120940000-120940600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
3 | chr4:120940200-120940600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
4 | chr4:120943800-120946800 | Weak transcription | Psoas Muscle | Psoas |